Precision Dermatology, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2012 | $55 M | No. 2 | $50 to $250 million | equity | SEC | |
| Nov 2010 | $19 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Precision Dermatology, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2012).
SEC Form D · Nov 2012
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Nov 2012
That is all the official record says: Precision Dermatology, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Precision Dermatology, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jeffrey N. Nugent | Executive officer | Nov 2012 |
| Steven N. Tannenbaum | Executive officer | Nov 2012 |
| Jeffrey M. Nugent | Executive officer | Nov 2010 |
| Adele N. Oliva | Director | Nov 2012 |
| Immanuel N. Thangaraj | Director | Nov 2012 |
| Jeffrey N. Nugent | Director | Nov 2012 |
| Michael N. Heffernan | Director | Nov 2012 |
| Patrick N. Heron | Director | Nov 2012 |
| William N. Crouse | Director | Nov 2012 |
| William N. Robb | Director | Nov 2012 |
| Immanuel J. Thangaraj | Director | May 2012 |
| Michael J. Heffernan | Director | May 2012 |
| Patrick J. Fortune | Director | May 2012 |
| Patrick J. Heron | Director | May 2012 |
| Immanuel M. Thangaraj | Director | Nov 2010 |
| Jeffrey M. Nugent | Director | Nov 2010 |
| Matthew M. Strobeck | Director | Nov 2010 |
| Michael M. Heffernan | Director | Nov 2010 |
| Patrick M. Fortune | Director | Nov 2010 |
| Patrick M. Heron | Director | Nov 2010 |